ADARs: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1.
about
New Insights into the Biological Role of Mammalian ADARs; the RNA Editing ProteinsAdenosine-to-inosine RNA editing and human diseaseREDIportal: a comprehensive database of A-to-I RNA editing events in humansProfiling RNA editing in human tissues: towards the inosinome AtlasRNA editing differently affects protein-coding genes in D. melanogaster and H. sapiensAbnormal expression of an ADAR2 alternative splicing variant in gliomas downregulates adenosine-to-inosine RNA editing.Human immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro.ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas.REDItools: high-throughput RNA editing detection made easy.Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma.Oligophrenin-1 (OPHN1), a gene involved in X-linked intellectual disability, undergoes RNA editing and alternative splicing during human brain development.Using REDItools to Detect RNA Editing Events in NGS Datasets.Adenosine deaminases that act on RNA induce reproducible changes in abundance and sequence of embryonic miRNAs.miR-EdiTar: a database of predicted A-to-I edited miRNA target sites.ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis.KSHV 2.0: a comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features.Structure and function of noncanonical nucleobases.ADAR enzyme and miRNA story: a nucleotide that can make the difference.The RNA editing enzymes ADARs: mechanism of action and human disease.Does RNA editing compensate for Alu invasion of the primate genome?Gene regulation in the immune system by long noncoding RNAs.ADAR RNA editing below the backbone.Genome-wide analysis of Alu editability.A high-throughput screen to identify enhancers of ADAR-mediated RNA-editing.A-to-I RNA editing independent of ADARs in filamentous fungi.Uncovering RNA Editing Sites in Long Non-Coding RNAs.Effects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures.When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference.ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion.Critical Analysis of Strand-Biased Somatic Mutation Signatures in TP53 versus Ig Genes, in Genome-Wide Data and the Etiology of Cancer
P2860
Q26782034-09E5228E-2886-4302-9A9E-75194E99A268Q26853110-FFC742DC-1C77-44E6-8534-A74A7510D351Q28584443-AC0A50D9-FDFB-4C54-936F-13FE334102A6Q28606601-4D974E34-9D3D-49E5-88AF-DA69C81937EDQ28607371-038BAFB8-108E-4B39-A44D-88EDAB5BAB69Q33646686-95C07153-2B28-4054-AD8E-A293244E3F0CQ34057801-36D53ECC-DB22-4BA7-A906-030E7AA87DFBQ34734481-2D9D2265-1265-4198-90DA-0ECD6421198EQ34762149-9782A9DD-5D26-460A-A3B8-D4F6A1783B20Q35079243-751AF150-0DF1-4B06-8150-1700D90A7104Q35123027-DE3E4B07-91E2-4CCB-ACE1-4CB40FA6341DQ35574261-2634CB1D-F033-496D-9411-53B69D4E9725Q36130858-A49DC8EA-D7A6-4EF1-A1AC-E0E9B30E008DQ36432217-BE94EAC6-85D3-4448-A918-E3F7998E4E13Q36628924-034F65D2-8558-46ED-8C62-730884CBEB70Q37488130-43505DD7-05E3-4DD0-AC2C-849667A28C9CQ38022547-B6241CBE-1CCE-461E-9DE2-79244D0FBDFAQ38164459-55CDFB7F-454B-4DCC-A143-BF63CCAC1BAEQ38207507-7635C3DA-9D7C-4E07-9CEC-B19861680F8FQ38264399-B03EDF95-8EBA-416E-A0F3-D6D98FFC4B4FQ38638798-38DD5517-D11E-452C-BDF2-6EFF2A76218AQ38755513-52698AF7-01B6-4AEA-A58A-D6C57F465889Q41003515-F4216ED4-C687-41C3-A041-38FF84C6B8BAQ41295215-CC52B58D-7EE7-47BC-B343-A26D5D05BA42Q41385153-6E6B6BA9-7881-42A6-BA5E-138B8EA53074Q41652013-2846A43C-AA09-446E-97F5-9C091BD74192Q43720264-93C98E4A-56EF-4C4D-9D1B-E83B16D78F76Q47252687-160CF13D-67D4-4CA1-AD0A-5CF651296541Q47901590-ADA109A2-B1A9-4719-8A30-C10DA2A89456Q59000617-B2C0376F-5FF5-4F15-910D-894DBA9BA864
P2860
ADARs: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ADARs: allies or enemies? The ...... disease: from cancer to HIV-1.
@en
ADARs: allies or enemies? The ...... disease: from cancer to HIV-1.
@nl
type
label
ADARs: allies or enemies? The ...... disease: from cancer to HIV-1.
@en
ADARs: allies or enemies? The ...... disease: from cancer to HIV-1.
@nl
prefLabel
ADARs: allies or enemies? The ...... disease: from cancer to HIV-1.
@en
ADARs: allies or enemies? The ...... disease: from cancer to HIV-1.
@nl
P2860
P1433
P1476
ADARs: allies or enemies? The ...... disease: from cancer to HIV-1.
@en
P2093
Angela Gallo
P2860
P304
P356
10.1111/J.1469-185X.2011.00186.X
P577
2011-06-20T00:00:00Z